Access the full text.
Sign up today, get DeepDyve free for 14 days.
Wong (2001)
Erythema nodosum as the first presenting complaint of asymptomatic pulmonary tuberculosisHong Kong J Emerg Med, 8(3)
McMahon (2021)
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases.J Am Acad Dermatol, 85
Ordieres-Ortega (2020)
Atypical erythema nodosum in a patient with COVID-19 pneumoniaDermatol Ther, 33
Mehta (2022)
Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India.J Eur Acad Dermatol Venereol, 36
Hsu (2021)
Erythema nodosum, after Medigen vaccination against COVID-19?J Formos Med Assoc
Suter (2020)
Erythema nodosum as a cutaneous manifestation of COVID-19 infectionBMJ Case Rep, 13(7)
Sipfle (2021)
Erythema nodosum-like rash in a COVID-19 patient: a case reportAm J Emerg Med, 40
Solomon (2021)
COVID-19 vaccine: side effects after the first dose of the Oxford AstraZeneca vaccine among health professionals in low-income country: Ethiopia.J Multidiscip Healthc, 14
Chowaniec (2016)
Erythema nodosum—review of the literature.Reumatologia, 54
Daneshgaran (2020)
Cutaneous manifestations of COVID-19: an evidence-based review.Am J Clin Dermatol, 21
Conforti (2020)
Cutaneous manifestations in confirmed COVID-19 patients: a systematic reviewBiology (Basel), 9
Freeman (2020)
The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries.J Am Acad Dermatol, 83
Kuriyama (2021)
Erythema nodosum-like eruption in coronavirus disease 2019: a case report and literature review of Asian countries.J Dermatol, 48
Galván Casas (2020)
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.Br J Dermatol, 183
Kroshinsky (2021)
Erythema nodosum.
Blake (2014)
Erythema nodosum—a review of an uncommon panniculitis.Dermatol Online J, 20
Del Valle (2020)
An inflammatory cytokine signature predicts COVID-19 severity and survival.Nat Med, 26
BackgroundOver the course of the pandemic, cutaneous manifestations of SARS-CoV-2 infections have been increasingly characterized, yet only a few cases of erythema nodosum (EN) are reported in the literature and international registries.Case presentationIn this report, we describe a case of tender, erythematous nodules that appeared acutely on the distal legs in a 48-year-old female with renal transplant following SARSs-CoV-2 infection complicated by prolonged fevers and pneumonia. The patient was diagnosed with a classic presentation of EN arising from a new and emerging trigger—COVID-19 infection. The cutaneous lesions resolved with conservative management.ConclusionsThis report highlights the importance of clinician awareness of the potential association of COVID-19 with a classic clinical presentation of EN and underscores that these cases can be managed with the same therapeutic repertoire as EN due to other aetiologies. Of note, use of systemic agents was not employed in this case, as our patient improved with conservative therapy alone.
Family Practice – Oxford University Press
Published: Jan 25, 2022
Keywords: case report; COVID-19; erythema nodosum; panniculitis; skin manifestations
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.